Evidence map›Paper›PMID 42725370›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026

Early impact of maternal RSV vaccination on bronchiolitis hospitalisation and critical care admissions in infants under age 3 months, England, September 2024 to March 2026.

Jonathan Broad, Matthew Wilson, Jaime Borjas-Howard, Merryn Voysey, Simon B Drysdale, Nick Andrews, Conall H Watson, Heather J Whitaker

Erratum issuedAbstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jonathan BroadDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.
Matthew WilsonDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.
Jaime Borjas-HowardDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Simon B DrysdaleOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Nick AndrewsDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.
Conall H WatsonDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.
Heather J WhitakerDepartment of Immunisation and Vaccine-Preventable Diseases, UK Health Security Agency, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We conducted a time series analysis of hospitalisation and critical care admissions to evaluate the impact of maternal respiratory syncytial virus (RSV) vaccination in England from September 2024 to March 2026 in infants < 3 months of age. All bronchiolitis admissions decreased by 39.3% (IRR: 0.607, 95% CI: 0.576-0.640), and RSV bronchiolitis admissions by 62.6% (IRR: 0.374, 95% CI: 0.344-0.407). We estimated a 41.0% reduction in bronchiolitis critical care admissions (IRR: 0.590, 95% CI: 0.531-0.657). Maternal vaccine coverage was 55.1%. These findings support efforts to expand vaccine uptake.

Indexed as

BronchiolitisCritical CareHospitalizationRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesVaccinationEnglandFemaleHumansInfantInfant, NewbornMalePregnancyRespiratory Syncytial Virus, HumanRespiratory Syncytial Virus VaccinesbronchiolitishospitalisationinfantsmaternalRSVvaccine

Identifiers

PMID42725370
PMCPMC13570235

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.